20
10/02/2013 1 Peter Bjerring, MD, PhD Medical Director and Head of The Laser Centre, Mølholm Hospital, Denmark Consultant, ZBC Multicare, Hilversum, Netherlands Professor, Faculty of Medicine, University of Swansea, Wales, UK Past President of the European Society for Lasers in Dermatology (ESLD) This work was not supported by any direct or non direct funding. It is under the author’s own responsibility DR Peter Bjerring

This work was not supported by any direct or non direct ... · One side treated with non-ablative fractional 1425 nm diode laser designed for home ... Home-treatment with fractional

Embed Size (px)

Citation preview

10/02/2013

1

Peter Bjerring, MD, PhD

Medical Director and Head of The Laser Centre, Mølholm Hospital, Denmark Consultant, ZBC Multicare, Hilversum, Netherlands

Professor, Faculty of Medicine, University of Swansea, Wales, UK Past President of the European Society for Lasers in Dermatology (ESLD)

This work was not supported by any direct or non direct funding. It is under the author’s own responsibility

DR Peter Bjerring

godfreytown
Typewritten Text
Content subject to publisher's copyright. Do not copy.

10/02/2013

2

¨  Many laser- and intense pulsed light (IPL) manufacturers have now developed low-power systems

¨  The technology is based on experience and knowledge from the professional device market

¨  The most popular indications for optical home treatments are:

¡  Hair removal - or hair management ¡  Skin rejuvenation (fine wrinkles, pigment treatment) ¡  Acne treatment ¡  Pigment reduction

10/02/2013

3

¡  Hair removal or hair management Visible light

¡  Skin rejuvenation (fine wrinkle treatment) Visible and IR light

¡  Pigment disorders Visible light

¡  Acne treatment – Blue and red light

¡  Vitiligo – UV-B

¡  Psoriasis – UV-B

¡  Eczema – UVB/UVA

¡  Seasonal Affected Disorder Visible light

¡  Rosacea Visible light

¡  Hypovitaminosis D UV-B

¡  Hair removal or hair management Visible light

¡  Skin rejuvenation (fine wrinkle treatment) Visible and IR light ¡  Pigment disorders Visible light

¡  Acne treatment – Blue and red light

¡  Vitiligo – UV-B

¡  Psoriasis – UV-B

¡  Eczema – UVB/UVA

¡  Seasonal Affected Disorder Visible light

¡  Rosacea Visible light

¡  Hypovitaminosis D UV-B

10/02/2013

4

¨  IPL based systems ¡  Typical maximum IPL pulse energy 7.5 - 30 J ¡  Pulse duration 2.5 - 60 ms ¡  Wavelengths 450-1200 nm

¨  Laser based systems ¡  Typical maximum laser pulse energy 22 J/cm2 ¡  Pulse durations up to 600 ms ¡  Wavelength 800-810 nm and 1400-1450 nm

¨  Fluorescence lamp based systems ¡  Narrow band UV-B lamps – 311nm ¡  White light

¨  LED based systems ¡  632 nm ¡  417 nm

Optical characteristics of home-use devices

¨  IPL based systems ¡  Typical maximum IPL pulse energy 7.5 - 30 J ¡  Pulse duration 2.5 - 60 ms ¡  Wavelengths 450-1200 nm

¨  Laser based systems ¡  Typical maximum laser pulse energy 22 J/cm2 ¡  Pulse durations up to 600 ms ¡  Wavelength 800-810 nm and 1400-1450 nm

¨  Fluorescence lamp based systems ¡  Narrow band UV-B lamps – 311nm ¡  White light

¨  LED based systems ¡  632 nm ¡  417 nm

A closer look on the laser-based home-use devices

10/02/2013

5

Philips ReAura diode laser 1435 nm fractional home-treatment device

Palomar Palovia diode laser 1420 nm fractional home-treatment device

From: Palovia product presentation

10/02/2013

6

From Palovia product presentation

Intenzity Innovation Inc.

Investigational device (not FDA approved)

10/02/2013

7

¨  Wavelength: 1425 nm ¨  Power: 900 mW ¨  Spot size at skin surface: 100µm ¨  Coverage per scan: 5% of skin surface

¨  Power density at skin surface: 10kW/cm2 ¡  Fluence: 50J/cm2 at 5mJ/pulse ¡  Fluence: 70J/cm2 at 7mJ/pulse

• Spots  are  separated    

• Each  radiated  zone  is  independent  limi3ng  thermal  diffusion    

• Tissue  necrosis  is  induced  -­‐  while  other  than  the  target  areas  are    substan3ally  unaffected  

10/02/2013

8

¨  Study design: ¡  randomized, double-blinded, prospective ¡  objective ultrasonographical measurements

¨  13 Volunteers ¡  Age 21 - 84 years, (avg. 53,2 years, SD: 17.9 years)

¨  3 treatments, 1 week intervals

¨  Follow-up 1 month after last treatment

¨  Split face study randomized treatment ¡  5 mJ/spot (one side of face) ¡  7 mJ/spot (other side of face)

¨ 

10/02/2013

9

¨  DermaScan (Cortex Technology, Denmark) ¡  20 MHz high frequency ultrasound

¨  Measurements: ¡  Skin ultrasonographic density (a measure of collagen content)

¡  Skin thickness

10/02/2013

10

Before after skin rejuvenation

5mJ treatment

15,0020,0025,0030,0035,0040,0045,0050,0055,00

Before After

Den

sity

in a

.u.

7mJ treatment

15,0020,0025,0030,0035,0040,0045,0050,0055,00

Before After

Den

sity

in a

.u.

10/02/2013

11

¨  Dermal density

Ø  Relative increase compared with before: 42.8% (SD: 29.1%)

Ø  The improvement is statistically significant, p=4.2 x 10-5

¨  Dermal density

Ø  Relative increase compared to before: 41.2% (SD: 26.2%)

Ø  The increase is statistically significant: p=5.5 x 10-6

10/02/2013

12

Lee WR, Shen SC, Kuo-Hsien W, Hu CH, Fang JY. J Invest Dermatol. 2003 Nov;121(5):1118-25.

Lasers and microdermabrasion enhance and control topical delivery of vitamin C

RESULTS: The Er:YAG laser showed the greatest enhancement of skin permeation of vitamin C The CO2 laser at a lower fluence promoted vitamin C permeation with no ablation of the stratum corneum or epidermal layers

10/02/2013

13

Fang JY, Lee WR, Shen SC, Fang YP, Hu CH. Br J Dermatol. 2004 Jul;151(1):132-40

Enhancement of topical 5-aminolaevulinic acid delivery by erbium:YAG laser and microdermabrasion RESULTS: The Er:YAG laser showed the greatest enhancement of ALA permeation, producing enhancement ratios from 4-fold to 246-fold relative to the control

10/02/2013

14

10/02/2013

15

¨  Normal skin, ventral side of both upper arms

¨  One side treated with non-ablative fractional 1425 nm diode laser designed for home treatment

¨  Symmetrical areas incubated with 5-ALA 0.5%

Intenzity Innovation , Inc.

Investigational device (not FDA approved)

10/02/2013

16

¨  Wavelength: 1425 nm ¨  Power: 900 mW ¨  Spot size at skin surface: 100µm ¨  Coverage per scan: 5% of skin surface

10/02/2013

17

¨  Non- treated side: ¡  10.4% increase of

fluorescence

¨  Micro-spot treated side: ¡  24.5% increase of

fluorescence

10/02/2013

18

Effect of local controlled heat on transdermal delivery of nicotine Petersen KK, Rousing ML, Jensen C, Arendt- Nielsen L, Gazerani P Int J Physiol Pathophysiol Pharmacol 2011, 30; 3(3): 236–242.

10/02/2013

19

¨  Home treatment fractional diode lasers are effective for peri-ocular skin rejuvenation

¨  Even non-ablative fractional laser treatment increases the uptake of topical drugs

¨  Simple, local skin heating may account for the increased uptake of topical products

¨  Further studies are needed to optimize home treatment laser parameters for enhanced delivery of topical drugs and cosmetics

10/02/2013

20

Peter Bjerring, MD, PhD

Medical Director and Head of The Laser Centre, Mølholm Hospital, Denmark Consultant, ZBC Multicare, Hilversum, Netherlands

Professor, Faculty of Medicine, University of Swansea, Wales, UK Past President of the European Society for Lasers in Dermatology (ESLD)